Skip to content

Anxiety Reduction Associated with Meditation: Home Study

Herbert B. Puryear, Charles Thomas Cayce, Mark A. Thurston

Perceptual and Motor Skills October 1, 1976 DOI: 10.2466/pms.1976.43.2.527 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Peer reviewed
Sample size 159
Population A.R.E. members
Intervention customary meditational techniques
Duration 28 days
Measures IPAT Anxiety Scale (Self-analysis Form), Mooney Problem Check List, Adult Form
Topics Anxiety Meditation
Key findings Participants who learned a new meditation technique via a home-study workbook reported a highly significant reduction in IPAT Anxiety Scale scores after 28 days, unlike those who continued their customary meditation. No significant changes appeared on the Mooney Problem Check List for either group.

Abstract

The effects of a new meditation technique were investigated; 159 A.R.E. members were randomly assigned either to a treatment or control group with the former learning the new technique using a home-study workbook manual and the latter continuing their customary meditational techniques. Analysis of variance (repeated measures) was used to compare group means of the scale scores yielded by two instruments, the IPAT Anxiety Scale (Self-analysis Form) and the Mooney Problem Check List, Adult Form (Mooney & Gordon, 1950). Unlike the control group, the treatment group reported highly significant reduction on the IPAT Anxiety Scale scores after 28 days of meditating with the new approach but no significant differences were found on the check list variables for either the treatment or control group. Implications of the findings for mental health professionals (psychiatrists, clinical and counseling psychologists) are briefly discussed.

Comparable studies

Other randomized controlled trials on anxiety, most cited first.

Study Year Design Participants
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety 2016 Randomized controlled trial n = 51
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Patients with cancer-related anxiety and depression 2016 Double-blind, placebo-controlled, crossover trial n = 29
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Hallucinogen-naïve adults reporting regular participation in religious or spiritual... 2006 Double-blind study n = 36
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Adults with advanced-stage cancer and anxiety 2010 Double-blind, placebo-controlled study n = 12

Citations in the library

Explore topics